c'ya, page-2

Goodbye Kalaharie. It is much harder when you are talking 6 figure losses, but I have to hold on and hope for the best now. I agree it is by no means the best for shareholders, but I still believe in the product that will reach the market eventually and despite all the negative posts on here, it will be profitable and people suffering from such a horrible disease may be able to have a better quality of life. Still the chance that big pharma may jump in prior to merge, but who bloody knows? Good luck in your future ventures and hope you make your money back elsewhere.